About 20 Trademarks found for “arju*”

Online retail store services featuring homewares, home office, dinnerware and kitchenware; Retail store services featuring homewares, home office, dinnerware and kitchenware

Color is not claimed as a feature of the mark.

Textile, fabric, and cloth goods, namely, table napkins of textile, tablecloths of textile, table runners of textile, fabric, or cloth, place mats and individual place mats of textile, fabric, and cloth, fitted and unfitted textile, fabric, and cloth furniture covers

BOTANICAL EXTRACTS FOR USE AS INGREDIENTS IN THE FOOD, PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRIES IN THE NATURE OF PLANT EXTRACTS, NAMELY, TURMERIC, AMLA, BOSWELLIA, ASWAGANDHA, POMEGRANATE, BRAHMI, CURCUMIN, CARALLUMA FIMBRIATA, CINNAMON, FENUGREEK, GARCINIA CAMBOGIA, GINGER ROOT, GREEN COFFEE, GUGGUL LIPID, GYMNEMA SYLVESTRE, MANGO BUTTER, ORGANIC GREEN TEA, OLIBANUM RESINOID, TRIPHALA, TRIBULUS TERRESTRIS USED IN THE MANUFACTURE OF CAPSULES, TABLETS AND SOFT GELS

3D printers; Electric glue guns; Embossing printing machines; Hot adhesive guns; Hot melt glue guns; Industrial paper cutting machines; Intaglio printing machines; Machines, namely, heat transfer presses; Machines, namely, sublimation heat transfer presses; Paper reeling machines; Photogravure printing presses; Printing plates; Printing rollers; Silk screen printing machines

The wording "Arjun" has no meaning in a foreign language.

Ale; Beer

Animal activated animal feeders; Automatic soap dispensers; Bath products, namely, body sponges; Bottle openers; Cake moulds; Cruet stands; Cruets; Dispensers for liquid soap; Drinkware; Eyelash combs; Gardening gloves; Golf brush; Hair brushes; Make-up brush holders; Make-up brushes; Manually actuated pump dispensers for attachment to containers for use in dispensing liquids; Paper muffin baking liners; Personal dispensers for pills or capsules for domestic use; Portable beverage dispensers; Soap dispensers

The wording "Arjungo" has no meaning in a foreign language.

Color is not claimed as a feature of the mark.

Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bile acid diarrhea; Pharmaceutical preparations for the treatment of tyrosine kinase inhibitor (TKI)-induced diarrhea; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of COVID-19; Pharmaceutical preparations for the treatment of inflammatory lung injury (ILI); Pharmaceutical preparations for the treatment of acute respiratory distress syndrome (ARDS); Pharmaceutical preparations for the treatment of social anxiety disorder; Pharmaceutical preparations for the treatment of performance anxiety; Pharmaceutical preparations for the treatment of public speaking anxiety; Pharmaceutical preparations for the treatment of circadian rhythm disorders; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder (DSPD); Pharmaceutical preparations for the treatment of non-24 hour sleep-wake disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndome; Pharmaceutical preparations for the treatment of nighttime sleep disturbances in patients with Smith-Magenis Syndrome (SMS); Pharmaceutical preparations for the treatment of major depressive disorder (MDD); Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of multiple myeloma; Pharmaceutical preparations for the treatment of Charcot-Marie-Tooth disease; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology